Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease. - Wikidata - wikimedia - TriplyDB

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

http://www.wikidata.org/entity/Q36944638

about

Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.New insights into sickle cell disease: mechanisms and investigational therapies.Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.Changes in Urine Microalbumin-to-Creatinine Ratio in Children with Sickle Cell Disease over Time.Changes in urine albumin to creatinine ratio with the initiation of hydroxyurea therapy among children and adolescents with sickle cell disease.Sickle Cell Trait and the Risk of ESRD in Blacks.UGT1A1 (TA)n genotype is not the major risk factor of cholelithiasis in sickle cell disease children.Prevalence and determinants of microalbuminuria in children suffering from sickle cell anemia in steady state Sickle cell disease and albuminuria: recent advances in our understanding of sickle cell nephropathy.The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle trait.Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.Severe anemia early in life as a risk factor for sickle-cell kidney disease.Improved Fetal Hemoglobin With mTOR Inhibitor-Based Immunosuppression in a Kidney Transplant Recipient With Sickle Cell Disease.Renal protection by atorvastatin in a murine model of sickle cell nephropathy.

P2860

Q36144830-88F65323-CA96-4A62-B13C-4FE961C1FB88 Q37143296-57E3D75A-0282-4C3F-9D4E-A4E2FBDDA4D8 Q39215776-FA79D55B-60D7-45D3-82A2-C45BD88CBEAD Q39256344-B2F33D4E-72E6-4831-8B16-03211F9D4E5C Q39371550-AD65C88E-BD18-4F3F-BBDE-489A90786E56 Q40298866-9998523C-8AB8-4BAC-BA30-1B227AC9C9E8 Q40422332-517ABF6A-1639-4143-96E8-DA4E90023365 Q41509966-7CA048F7-D7B1-4B17-BA67-051F93582ADF Q41510616-6091F1EE-A28C-46E8-8CD4-154640C9C2DB Q47129770-912659B4-A16A-4BE6-92FF-9620BB4BD5C1 Q48090226-6A024DAB-3EB2-4625-8011-C3B6B0E3F95C Q48179508-D3BA8CEE-CA77-43C9-977E-EBA7481F8224 Q51836741-EFA9FB1A-EEA0-4CEE-ACED-05C421535329 Q52727244-D29D37F9-14FC-4C96-82C7-8D17DC1E32F3

P2860

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

http://www.wikidata.org/entity/Q36944638

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

@en

type

label

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

@en

prefLabel

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.

@en

P1433

Q36944638-C04833E1-58D2-4C64-8556-CFF9104F80D0

P1476

Q36944638-AE5F23D5-38F8-4C65-BD9B-764426B9D49C

P2093

Q36944638-23A0C1E2-DF98-4534-A2D3-EAB0A6C16911

Q36944638-4F169368-8F35-4942-94B6-226A8DA9B2E4

Q36944638-5645F59E-927E-4938-A722-85D36040760B

Q36944638-6C0092B3-5DEF-4156-B01D-27149793C2D3

Q36944638-7897BA4E-3163-4873-BFCC-C15C9393B069

Q36944638-7CCA2E53-5AB7-425E-9CC0-187291EEEAAB

Q36944638-986B862D-16C8-4B69-B46A-71EF28F000D6

Q36944638-9B417364-8E60-47FC-A62A-D480269533BE

Q36944638-9E824F28-454B-4FD6-886C-F40FA1FBF591

Q36944638-A48901AE-E793-4414-BBED-AA3459A9344F

P2860

Q36944638-059E49F1-661F-4462-AA83-1D17604A07A7

Q36944638-0DC8AD22-0F94-45ED-B32E-404F89D3EDC6

Q36944638-0F2754DF-EA37-45CF-9A2F-C00206F84D9E

Q36944638-1D8F2B55-B21B-4502-884D-4A122EF38031

Q36944638-217A620B-4880-48D4-B2A8-B2A41E077C83

Q36944638-295C4FC5-5ABD-4DDE-9C9C-CFF74C02BF61

Q36944638-2CAA1DAF-BAA4-4254-8ABD-353228B8ED17

Q36944638-2E6DFEF0-2948-4FAD-9F02-81EBCEBF9132

Q36944638-34DE19AF-47F2-42EB-BBA9-0BA457E53EF8

Q36944638-53C82521-6B04-4CEA-B882-60028EAC834F

P304

Q36944638-ECB1D706-2B80-4505-AC1F-8E4BA0A933AB

P31

Q36944638-DE7C5739-9C7F-4994-8619-2963F034EFBB

P356

Q36944638-DE48F305-9A7D-4760-B36C-0708BFE678BE

P433

Q36944638-50A78C61-FE74-4560-A263-86E575890EE7

P478

Q36944638-56CC957D-8EA7-4984-8F2F-7A367B8354C2

P50

Q36944638-40B2748E-4BBC-4CEB-A1EE-726CD57CB4B6

Q36944638-664431AC-DFDC-45DF-BDC2-F09E075BCEF1

Q36944638-CC90EA10-A254-4E1C-A327-43A38ECC1ADC

Q36944638-D7A701B5-D642-4656-9FAF-47999D77D071

Q36944638-D9A043BF-D64F-47CC-8309-86C535E9AE9D

P577

Q36944638-D400BA78-0C4D-477C-BBA3-F215670EC0BE

P5875

Q36944638-0C9D08FB-9996-458D-BEB2-460F4684DE5D

P698

Q36944638-00500DDD-E842-4082-9AA1-4B7618A384E3

P921

Q36944638-D238B05B-4C16-4D63-89F7-E6CABAA6120E

P932

Q36944638-40A4BE36-F188-45BE-AD19-183DDF3CBBE6

P356

P1433

Journal of the American Society of Nephrology

P1476

Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease

@en

P2093

Anoosha Habibi

http://www.w3.org/2001/XMLSchema#string

Bertrand Godeau

http://www.w3.org/2001/XMLSchema#string

Frédéric Galacteros

http://www.w3.org/2001/XMLSchema#string

Gaetana Di Liberto

http://www.w3.org/2001/XMLSchema#string

Justine Gellen-Dautremer

http://www.w3.org/2001/XMLSchema#string

Marie Georgine Rakotoson

http://www.w3.org/2001/XMLSchema#string

Philippe Grimbert

http://www.w3.org/2001/XMLSchema#string

Philippe Lang

http://www.w3.org/2001/XMLSchema#string

Philippe Remy

http://www.w3.org/2001/XMLSchema#string

Stéphane Moutereau

http://www.w3.org/2001/XMLSchema#string

P2860

The glomerulopathy of sickle cell disease

Glomerular lesions in patients with sickle cell disease.

First evidence of subclinical renal tubular injury during sickle-cell crisis.

Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease

Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: a prospective observational cohort study

Hyperfiltration is associated with the development of microalbuminuria in patients with sickle cell anemia

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

P304

1847-1853

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2014111126

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Etienne Audureau

Djillali Sahali

Orianne Wagner-Ballon

Pablo Bartolucci

P577

2015-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284279391

http://www.w3.org/2001/XMLSchema#string

P698

26586692

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

4884099

http://www.w3.org/2001/XMLSchema#string